NovaBay Pharmaceuticals logo
NovaBay Pharmaceuticals NBY
$ 0.52 3.99%

Квартальный отчет 2024-Q3
добавлен 07.11.2024

report update icon

NovaBay Pharmaceuticals Мультипликаторы 2011-2024 | NBY

Мультипликаторы по годам NovaBay Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.2 -0.1 -3.2 -1.4 -4.9 -7.7 -2.8 -0.4 -2.1 -2.7 -5.4 -7.1

P/S

0.0 0.2 0.0 3.6 2.0 2.6 3.1 3.0 1.6 30.1 12.5 5.5 3.3

EPS

-4.0 -10.1 -5.3 -0.3 -0.5 -0.4 -0.5 -1.4 -6.8 -7.7 -10.5 -0.2 -0.2

EV (Enterprise Value)

3.18 млн 2.96 млн 6.78 млн 26.6 млн 16.5 млн 33.5 млн 61 млн 35 млн 15 млн 32 млн 40.2 млн 30.4 млн 34.3 млн

EBITDA per Share

-1.79 -8.88 -7.06 -0.159 -0.431 -0.449 -0.471 -1.16 -7.49 -8.39 -9.93 -6.76 -3.78

EV/EBITDA

-0.7 -3.7 -1.0 -3.8 -7.4 -2.5 -0.3 -1.6 -2.2 -3.2 -7.1

PEG

-0.0 -0.0 -0.0 0.51 0.06 -0.26 -0.12 -0.03 -0.03 -0.08 0.04 0.27 0.64

P/B

0.2 0.2 0.0 2.9 13.6 6.5 21.9 5.1 -1.4 17.2 5.1 2.7 3.9

P/CF

-0.1 -0.4 -0.1 -7.5 -1.7 -5.8 -8.7 -2.9 -0.4 -2.1 -3.3 -5.7 -11.1

ROE %

-290.89 -100.51 -57.26 -89.62 -992.60 -132.12 -285.39 -185.20 372.17 -822.19 -188.37 -50.02 -54.42

ROA %

-106.71 -64.69 -24.29 -72.44 -86.08 -69.92 -73.45 -85.50 -373.70 -201.59 -102.50 -36.53 -31.85

ROCE %

-229.21 -136.60 -87.13 -51.80 -169.89 -142.75 -143.35 -99.31 -4732.88 -402.62 -128.80 -51.73 -32.92

Current Ratio

1.6 2.8 1.7 5.0 1.6 2.2 1.8 3.3 1.0 2.1 4.1 5.8 5.1

DSO

33.9 25.0 - 40.6 59.0 101.9 74.4 70.1 44.7 94.5 82.3 49.5 0.1

DIO

168.7 183.4 189.4 55.9 103.3 68.0 66.1 129.3 389.3 391.3 520.5 - -

DPO

59.0 58.6 66.6 27.8 69.5 133.8 61.1 67.4 718.7 1400.7 3771.7 - -

Операционный цикл

202.6 208.4 189.4 96.5 162.3 169.9 140.5 199.4 434.0 485.8 602.8 - -

Финансовый цикл

143.5 149.9 122.7 68.8 92.8 36.1 79.4 132.0 -284.7 -914.8 -3168.9 - -

Все данные представлены в валюте USD

Мультипликаторы поквартально NovaBay Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.6 -1.37 -0.15 - -13.11 -44.43 -0.85 - -3.61 -1.43 -0.08 - -0.05 -0.04 -0.04 - -0.08 -0.15 -0.06 - -0.01 -0.14 -0.25 - -0.09 -0.09 -0.13 - -0.16 -0.11 -0.26 - -0.34 -0.36 -1.24 - -1.77 -1.84 -2.13 - -0.08 -0.06 -0.08 - -0.1 -0.11 -0.11 - - -0.08 -0.09 - - 0.02 -0.08

EBITDA per Share

-0.28 -0.9 -0.1 - -5.11 -11.4 -0.65 - -0.27 -1.41 -1.64 - -0.05 -0.04 -0.04 - -0.05 -0.03 -0.05 - -0.07 -0.07 -0.24 - -0.1 -0.12 -0.14 - -0.14 -0.11 -0.25 - -0.19 -0.3 -1.13 - - - -2.12 - -0.08 -0.07 -0.09 - -0.07 -0.11 -0.02 - 0.01 -0.09 -0.08 - - 0.03 -0.08

ROE %

-1889.89 -1801.80 -2082.46 -68.31 -69.29 -45.31 -35.22 -15.30 -39.74 -63.20 -66.10 -54.85 -81.00 -82.70 -102.50 -75.38 -104.36 -107.19 -327.85 -716.55 -747.59 -749.66 -524.69 -106.52 -240.09 -342.61 -377.54 -355.20 -407.81 -326.85 -297.73 -161.99 -59.17 96.27 230.01 -17.23 -245.53 -576.65 -831.72 -580.41 -625.60 -442.48 -330.82 -796.31 -795.74 -749.99 -718.30 -33.29 -32.16 -31.59 -11.20 -15.59 1.13 4.55 -21.28

ROA %

-145.31 -127.72 -100.06 -38.12 -38.73 -25.66 -22.95 -11.06 -29.76 -47.86 -51.52 -43.16 -64.29 -66.73 -82.48 -60.93 -63.45 -44.82 -37.70 -62.14 -78.57 -92.49 -87.17 -56.37 -80.65 -88.50 -88.77 -81.32 -105.61 -105.62 -105.86 -74.79 -178.04 -257.00 -335.77 -256.41 -312.38 -265.11 -207.89 -142.31 -166.90 -135.51 -122.34 -433.32 -432.90 -407.90 -393.60 -24.32 -23.65 -23.40 -9.17 -9.13 0.66 2.66 -12.45

ROCE %

-1460.73 -1371.67 -1554.61 -37.32 -40.64 -34.03 -35.43 -30.41 -54.85 -75.98 -78.90 -54.87 -71.61 -63.90 -56.01 -37.90 -213.85 -373.06 -506.09 -736.07 -772.59 -633.16 -533.48 -126.36 -244.76 -326.64 -352.32 -331.73 -360.76 -271.39 -235.20 -126.07 -21.16 112.77 239.62 -16.68 -239.24 -566.71 -866.89 -648.11 -683.12 -495.57 -339.44 -124.69 -125.45 -91.19 -62.92 -38.91 -42.63 -45.60 -20.43 -19.83 -3.72 4.71 -20.82

Current Ratio

1.4 0.9 1.0 1.6 2.2 2.1 2.5 2.8 2.6 3.7 3.5 1.7 4.3 5.7 4.6 5.2 5.2 5.2 5.2 1.1 1.1 1.1 1.1 2.1 2.1 2.1 2.1 1.4 1.4 1.4 1.4 1.9 1.9 1.9 1.9 0.5 0.5 0.5 1.4 1.3 1.3 1.3 1.3 2.2 2.2 2.2 2.2 3.7 3.7 3.7 3.7 2.4 2.4 2.4 2.4

DSO

23.4 24.4 24.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

63.1 77.0 66.9 - 398.5 189.5 446.6 - 247.4 181.1 208.2 - 105.8 113.8 146.2 - 103.5 27.2 86.4 - 112.0 111.4 103.3 - 77.0 53.3 142.5 - 88.3 65.9 106.8 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

87.8 132.8 110.3 - 135.3 66.8 137.6 - 63.7 62.2 81.3 - 100.1 77.3 113.8 - 51.4 13.5 49.7 - 75.3 75.0 118.0 - 151.4 105.0 184.9 - 81.6 60.9 71.5 - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

86.5 101.3 91.4 - 398.5 189.5 446.6 - 247.4 181.1 208.2 - 105.8 113.8 146.2 - 103.5 27.2 86.4 - 112.0 111.4 103.3 - 77.0 53.3 142.5 - 88.3 65.9 106.8 - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

-1.3 -31.5 -18.9 - 263.2 122.7 309.1 - 183.7 118.9 126.8 - 5.7 36.5 32.4 - 52.1 13.7 36.7 - 36.6 36.5 -14.7 - -74.5 -51.6 -42.4 - 6.7 5.0 35.4 - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD